Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Jurnal Paradigma Ekonomika
Ndelu Lembo, Helmina
Unknown Affiliation
Economics, Econometrics & Finance

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Kinerja keuangan perusahaan: tinjuan analisis rasio likuiditas dan profitabilitas Sularsih, Hermi; Junaidar Handayanto, Adrian; Himawan W, Sukarno; Ndelu Lembo, Helmina
Jurnal Paradigma Ekonomika Vol. 18 No. 4 (2023): Jurnal Paradigma Ekonomika
Publisher : Program Studi Ekonomi Pembangunan Fakultas Ekonomi dan Bisnis Universitas Jambi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22437/jpe.v18i4.28930

Abstract

The aim of this research is to find out the financial performance of pharmaceutical companies listed on the Indonesia Stock Exchange for the 2020–2022 period in terms of liquidity and profitability. This research is quantitative research using an associative approach. The population used in this research is all pharmaceutical companies registered on the IDX. The sampling technique used in this research was purposive sampling. So the number of samples in this study was ten pharmaceutical companies listed on the IDX which were selected according to predetermined sampling criteria. Data collection in this research is documentation. Data analysis methods use descriptive statistics, multiple linear regression analysis, classical assumption testing, and hypothesis testing. Research findings show that liquidity and profitability have a positive and significant effect on the financial performance of pharmaceutical companies listed on the IDX. Profitability shows the company's potential to generate long-term income, while liquidity ensures that there is sufficient cash to carry out daily operations.
Co-Authors Himawan W, Sukarno Junaidar Handayanto, Adrian Sularsih, Hermi